| Code | 34904 | ||||||||||
| MA number | EU/1/00/152/005 | ||||||||||
| Product Form: | plv inu 1x0,5 ml (1x liek.+1x striek.+2x ihla) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | GlaxoSmithKline Biologicals S.A., Belgium | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intramuscular use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application |
| MA issued: | 23.10.2000 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
DHPC_Boostrix Polio-Infanrix Hexa-Infanrix Polio_17.10.2024.pdf
|
| Safety feature | Yes |
| Data update: | 10.12.2019 |
